Patricia A Cooper Selected Research

ICT 2552

1/2016

The use of thermographic imaging to evaluate therapeutic response in human tumour xenograft models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patricia A Cooper Research Topics

Disease

13	Neoplasms (Cancer) 01/2020 - 02/2002
3	Colonic Neoplasms (Colon Cancer) 12/2011 - 08/2007
3	Breast Neoplasms (Breast Cancer) 11/2011 - 02/2002
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2019
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 11/2010
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 01/2018
2	Lung Neoplasms (Lung Cancer) 01/2019 - 01/2016
2	Carcinoma (Carcinomatosis) 12/2006 - 02/2002
1	Bacterial Infections (Bacterial Infection) 10/2020
1	Inflammation (Inflammations) 10/2020
1	Hypoxia (Hypoxemia) 01/2018
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2013
1	Transitional Cell Carcinoma 01/2013
1	Neoplasm Metastasis (Metastasis) 12/2011
1	Disease Progression 11/2011
1	Necrosis 08/2007
1	Adenocarcinoma 12/2006

Drug/Important Bio-Agent (IBA)

3	LigandsIBA 01/2022 - 10/2017
3	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2021 - 02/2002
3	Pharmaceutical PreparationsIBA 01/2021 - 01/2013
3	ProdrugsIBA 01/2013 - 02/2002
2	EnzymesIBA 01/2021 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 03/2010
2	SilverIBA 09/2018 - 10/2017
2	carbeneIBA 09/2018 - 10/2017
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 02/2002
2	Cytotoxins (Cytolysins)IBA 01/2016 - 01/2013
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 07/2004
2	DNA (Deoxyribonucleic Acid)IBA 11/2011 - 12/2006
2	auristatin PYEIBA 03/2010 - 08/2007
2	Phosphates (Orthophosphate)IBA 03/2008 - 02/2004
1	Coordination ComplexesIBA 01/2022
1	phosphine (phosphane)IBA 01/2022
1	maleinitriledithiolateIBA 01/2022
1	RutheniumIBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2021
1	CarcinogensIBA 01/2021
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 10/2020
1	Glycogen Synthase (Synthase I)IBA 01/2019
1	Chir 99021IBA 01/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2019
1	ICT 2552IBA 01/2016
1	DuocarmycinsIBA 01/2013
1	(1- (chloromethyl)- 1,2- dihydropyrrolo(3,2- e)indol- 3(6H)- yl)(5- methoxy- 1H- indol- 2- yl)methanoneIBA 01/2013
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 01/2013
1	Dihydrotachysterol (AT 10)IBA 12/2011
1	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 12/2011
1	Fluorescent Dyes (Fluorescent Probes)IBA 12/2011
1	CYT997IBA 12/2011
1	Antineoplastic Agents (Antineoplastics)IBA 11/2011
1	diphenyl (biphenyl)IBA 11/2010
1	OsmiumIBA 11/2010
1	4-cymene (p-cymene)IBA 11/2010
1	pancratistatinIBA 03/2008
1	SodiumIBA 03/2008
1	C 1311IBA 12/2006
1	Biological ProductsIBA 07/2004
1	fosbretabulin (combretastatin A4)IBA 02/2004
1	TubulinIBA 02/2004
1	combretastatin A-1IBA 02/2004
1	2- (4- amino- 3- methylphenyl)- 5- fluorobenzothiazoleIBA 02/2002

Therapy/Procedure

2	Aftercare (After-Treatment) 08/2007 - 02/2002
1	Therapeutics 01/2019
1	Drug Therapy (Chemotherapy) 01/2019